Prognostic impact of insertion site in acute myeloid leukemia with FLT3 internal tandem duplication: results from the RATIFY study (Alliance)
      Google Scholar   
Citation:
Blood vol 132 (Suppl 1) 435
Meeting Instance:
ASH 2018
Year:
2018
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epreprint
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
3327   3696  
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
Novartis  
Grants:
U10CA180821, U10CA180882, U24CA196171, U10CA180820, U10CA180791 U10CA180863, (CCSRI) #704970 U10CA180888  
Corr. Author:
 
Authors:
                                                           
Networks:
GULFSOUTH, LAPS-IL057, LAPS-MA036   
Study
CALGB-10603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: